Article | June 25, 2026

Glove Integrity Testing, What Changes With The New EU GMP Annex 1 Revision

The revised Annex 1 of EU GMP introduces clearer expectations for sterile manufacturing, with a sharper focus on glove integrity testing in isolator environments. Defined testing intervals—now required at least at the start and end of each batch or production session—remove long-standing ambiguity and place greater operational demands on manufacturers. This shift makes testing frequency, consistency, and reliability central to compliant production. At the same time, equipment selection becomes more critical than ever. Factors such as minimizing false positives and negatives, reducing setup time, and ensuring ease of use and cleaning can directly influence production efficiency and risk management.

As the updated regulation takes effect, aligning testing strategies and technologies with these new requirements will be essential for maintaining compliance without compromising throughput.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online